Roche, Genentech in talks for $95 a share deal
Roche Holding AG
The new price was enough to get both sides to the table, said the source, who was not authorized to speak to the press.
Roche and Genentech declined to comment.
(Reporting by Jessica Hall; editing by Jeffrey Benkoe)
(For more M&A news and our DealZone blog, go to http://www.reuters.com/investing/news/mergers)
© Copyright Thomson Reuters 2024. All rights reserved.
Join the Discussion
Editor's pick